Diabetes Information

 

On these pages, expect to find diabetes-related information tailored to patients with Type 1 and Type 2 diabetes, with links to FDA web pages and other trusted government web sites. FDA is committed to getting accurate, science-based information in the hands of people with diabetes so they can use foods, medicines, and devices to maintain and improve their health. With the incidence of diabetes skyrocketing, it is important to FDA that we do what we can to inform patients.

Diabetes is the seventh leading cause of death in the United States. An estimated 25.8 million people in the U.S.—approximately 8.3% of the population—have diabetes. (What is Diabetes?)  

 

Subscribe to FDA Updates

E-mail lists managed by GovDelivery

• FDA Diabetes Monitor - FDA's Diabetes e-mail list delivers updates on safety and regulatory issues related to diabetes, including product approvals, safety warnings, notices of upcoming public meetings, and notices about proposed regulatory guidances.
• Patient Network News - A twice monthly newsletter containing FDA-related information on a variety of topics, including new product approvals, significant labeling changes, safety warnings, public meetings, and more.
• MedWatch E-list - Clinically important medical product safety alerts, delivered via e-mail and/or SMS text messages.

 

More Information

The following FDA websites can help guide your search for medicines and devices.

• Division of Small Manufacturers, International and Consumer Assistance (DSMICA)can assist with questions on a variety of medical device topics.
• Division of Drug Information (DDI) is the FDA focal point for public inquiries regarding human drug products.